T. Rowe Price Associates
HURA

T. Rowe Price Associates’s TuHURA Biosciences HURA Stock Holding History

T. Rowe Price Associates’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$24K Hold
13,128
– – ﹤0.01% 3114
2025
Q4 		$10K Hold
13,128
– – ﹤0.01% 3086
2025
Q3 		$33K Hold
13,128
– – ﹤0.01% 3029
2025
Q2 		$30K Buy
+13,128
New +$44.4K ﹤0.01% 3038

Other funds holding HURA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return

T. Rowe Price Associates's HURA Position: Q1 2026 in Review

T. Rowe Price Associates held its TuHURA Biosciences (HURA) position steady in Q1 2026 at 13,128 shares worth $24K. The position accounts for ﹤0.01% of the portfolio, ranked #3114.

T. Rowe Price Associates first reported a position in HURA in Q2 2025 and has held it in 4 quarters since. The position peaked at $33K in Q3 2025. 89 funds tracked by Wall St. Rank hold HURA as of Q1 2026.

  • T. Rowe Price Associates held 13,128 shares of TuHURA Biosciences worth $24K as of Q1 2026.
  • T. Rowe Price Associates left its TuHURA Biosciences share count unchanged in Q1 2026.
  • TuHURA Biosciences made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #3114 holding.
  • T. Rowe Price Associates first reported a position in TuHURA Biosciences in Q2 2025 and has held it in 4 quarters since.
  • T. Rowe Price Associates's TuHURA Biosciences position peaked at $33K in Q3 2025.
  • 89 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.